116 related articles for article (PubMed ID: 20523198)
1. Bisphosphonate-induced orbital inflammation.
Mbekeani JN; Slamovits TL
J Neuroophthalmol; 2010 Jun; 30(2):205-6; author reply 206. PubMed ID: 20523198
[No Abstract] [Full Text] [Related]
2. Bisphosphonate-Induced Orbital Inflammation: A Case Series and Review.
Pirbhai A; Rajak SN; Goold LA; Cunneen TS; Wilcsek G; Martin P; Leibovitch I; Selva D
Orbit; 2015; 34(6):331-5. PubMed ID: 26540241
[TBL] [Abstract][Full Text] [Related]
3. Orbital inflammation after zoledronate infusion: an emerging complication.
Rahimy E; Law SK
Can J Ophthalmol; 2013 Feb; 48(1):e11-2. PubMed ID: 23419305
[No Abstract] [Full Text] [Related]
4. A Case Series and Review of Bisphosphonate-associated Orbital Inflammation.
Lefebvre DR; Mandeville JT; Yonekawa Y; Arroyo JG; Torun N; Freitag SK
Ocul Immunol Inflamm; 2016; 24(2):134-9. PubMed ID: 25153041
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid infusion and orbital inflammatory disease.
Sharma NS; Ooi JL; Masselos K; Hooper MJ; Francis IC
N Engl J Med; 2008 Sep; 359(13):1410-1. PubMed ID: 18815406
[No Abstract] [Full Text] [Related]
6. Safety of bisphosphonates in the treatment of osteoporosis.
Recker RR; Lewiecki EM; Miller PD; Reiffel J
Am J Med; 2009 Feb; 122(2 Suppl):S22-32. PubMed ID: 19187809
[TBL] [Abstract][Full Text] [Related]
7. Another case of bisphosphonate-induced orbital inflammation.
Yang EB; Birkholz ES; Lee AG
J Neuroophthalmol; 2010 Mar; 30(1):94-5. PubMed ID: 20182217
[No Abstract] [Full Text] [Related]
8. Bisphosphonate-induced fractures: nature strikes back?
Aspenberg P
Acta Orthop; 2008 Aug; 79(4):459-60. PubMed ID: 18766476
[No Abstract] [Full Text] [Related]
9. [Bisphosphonate therapy for osteoporosis and bone strength].
Kishimoto H
Clin Calcium; 2006 Sep; 16(9):1513-19. PubMed ID: 16951477
[TBL] [Abstract][Full Text] [Related]
10. A once-yearly IV bisphosphonate for osteoporosis.
Obstet Gynecol; 2008 May; 111(5):1208-9. PubMed ID: 18448761
[No Abstract] [Full Text] [Related]
11. Bisphosphonate medications--the good, the bad, and the ugly.
Bourgeois SL
Tex Dent J; 2009 Jul; 126(7):596-604. PubMed ID: 19753815
[No Abstract] [Full Text] [Related]
12. Implications of bisphosphonate use for the dentist: an introduction.
Kurtzman GM; Silverstein LH; Peden J; Shatz PC
Dent Today; 2006 Jun; 25(6):80, 82-5; quiz 85. PubMed ID: 16792113
[No Abstract] [Full Text] [Related]
13. I've heard that bisphosphonate medications used for osteoporosis can affect a person's jaw. Can you tell me more?
Mayo Clin Womens Healthsource; 2008 Sep; 12(9):8. PubMed ID: 18667975
[No Abstract] [Full Text] [Related]
14. More on reports of esophageal cancer with oral bisphosphonate use.
Solomon DH; Patrick A; Brookhart MA
N Engl J Med; 2009 Apr; 360(17):1789-90; author reply 1791-2. PubMed ID: 19391255
[No Abstract] [Full Text] [Related]
15. [Bisphosphonate or Raloxifene?: which drug we can choose for osteoporotic patients?].
Miki T; Saito S
Clin Calcium; 2006 Jan; 16(1):167-74. PubMed ID: 16397368
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate therapy and dental treatment.
Phillips G
J Indiana Dent Assoc; 2007-2008 Winter; 86(4):4-8. PubMed ID: 18363257
[No Abstract] [Full Text] [Related]
17. Bisphosphonate therapy and dental treatment.
Phillips G
J Mich Dent Assoc; 2009 Aug; 91(8):40, 42-5. PubMed ID: 19722373
[No Abstract] [Full Text] [Related]
18. Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis.
Dello Russo NM; Jeffcoat MK; Marx RE; Fugazzotto P
Int J Oral Maxillofac Implants; 2007; 22(1):146-53. PubMed ID: 17340909
[No Abstract] [Full Text] [Related]
19. Osteoporosis drugs not linked to atrial fibrillation.
Harv Heart Lett; 2009 Apr; 19(8):6. PubMed ID: 19685565
[No Abstract] [Full Text] [Related]
20. Treating osteoporosis.
Smith G; Stassen L; Flint S
Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
